1. Association Between Skin Reaction and Clinical Benefit in Patients Treated with Anti‐Programmed Cell Death 1 Monotherapy for Advanced Non‐Small Cell Lung Cancer. (7th November 2019) Authors: Aso, Mari; Toi, Yukihiro; Sugisaka, Jun; Aiba, Tomoiki; Kawana, Sachiko; Saito, Ryohei; Ogasawara, Takahiro; Tsurumi, Kyoji; Ono, Kana; Shimizu, Hisashi; Domeki, Yutaka; Terayama, Keisuke; Kawashima, Yosuke; Nakamura, Atsushi; Yamanda, Shinsuke; Kimura, Yuichiro; Honda, Yoshihiro; Sugawara, Shunichi Journal: Oncologist Issue: Volume 25:Number 3(2020) Page Start: e536 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Association of immune‐related pneumonitis with clinical benefit of anti‐programmed cell death‐1 monotherapy in advanced non‐small cell lung cancer. (13th June 2021) Authors: Ono, Kana; Ono, Hirotaka; Toi, Yukihiro; Sugisaka, Jun; Aso, Mari; Saito, Ryohei; Kawana, Sachiko; Aiba, Tomoiki; Odaka, Tetsuo; Matsuda, Suguru; Saito, Shin; Narumi, Akane; Ogasawara, Takahiro; Shimizu, Hisashi; Domeki, Yutaka; Terayama, Keisuke; Kawashima, Yosuke; Nakamura, Atsushi; Yamanda, Sh... Journal: Cancer medicine Issue: Volume 10:Number 14(2021) Page Start: 4796 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Current status of first‐line treatment with pembrolizumab for non–small‐cell lung cancer with high PD‐L1 expression. Issue 6 (15th April 2022) Authors: Ikezawa, Yasuyuki; Mizugaki, Hidenori; Morita, Ryo; Tateishi, Kazunari; Yokoo, Keiki; Sumi, Toshiyuki; Kikuchi, Hajime; Kitamura, Yasuo; Nakamura, Atsushi; Kobayashi, Maki; Aso, Mari; Kimura, Nozomu; Yoshiike, Fumiaki; Furuta, Megumi; Tanaka, Hisashi; Sekikawa, Motoki; Hachiya, Tsutomu; Nakamura,... Journal: Cancer science Issue: Volume 113:Issue 6(2022) Page Start: 2109 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗